Paul W. Hawran, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 5,000 shares at $3.23 ($16K) on 2011-09-14, disclosed to the SEC on 2011-09-15.
Open-market purchase of $16k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.18 | 3,000 | $10K | 59.6% |
| 2 | $3.23 | 2,000 | $6K | 40.4% |
| Total | $3.20 avg | 5,000 | $16K | 100% |
| Filing → |
| CYTX | BUY | 2009-11-25 | $25K | — | Filing → |
| CYTX | BUY | 2009-11-24 | $24K | — | Filing → |
| CYTX | BUY | 2009-11-18 | $85K | — | Filing → |